HK1078006A1 - Immediate release pharmaceutical granule compositions and a continuous process for making them - Google Patents

Immediate release pharmaceutical granule compositions and a continuous process for making them

Info

Publication number
HK1078006A1
HK1078006A1 HK05109984.4A HK05109984A HK1078006A1 HK 1078006 A1 HK1078006 A1 HK 1078006A1 HK 05109984 A HK05109984 A HK 05109984A HK 1078006 A1 HK1078006 A1 HK 1078006A1
Authority
HK
Hong Kong
Prior art keywords
making
continuous process
immediate release
release pharmaceutical
granule compositions
Prior art date
Application number
HK05109984.4A
Other languages
English (en)
Inventor
Jean-Paul Remon
Chris Vervaet
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of HK1078006A1 publication Critical patent/HK1078006A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK05109984.4A 2002-03-06 2005-11-09 Immediate release pharmaceutical granule compositions and a continuous process for making them HK1078006A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205253.8A GB0205253D0 (en) 2002-03-06 2002-03-06 Immediate release pharmaceutical granule compositions and a continuous process for making them
PCT/BE2003/000040 WO2003074031A1 (fr) 2002-03-06 2003-03-05 Compositions pharmaceutiques en granules a liberation immediate et procede de fabrication de celles-ci en continu

Publications (1)

Publication Number Publication Date
HK1078006A1 true HK1078006A1 (en) 2006-03-03

Family

ID=9932403

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05109984.4A HK1078006A1 (en) 2002-03-06 2005-11-09 Immediate release pharmaceutical granule compositions and a continuous process for making them

Country Status (22)

Country Link
US (4) US20050058705A1 (fr)
EP (1) EP1480622B1 (fr)
KR (1) KR20040091099A (fr)
CN (1) CN1638738B (fr)
AR (1) AR038880A1 (fr)
AT (1) ATE418327T1 (fr)
AU (1) AU2003215449B2 (fr)
BR (1) BR0308231A (fr)
CA (1) CA2477890C (fr)
DE (1) DE60325461D1 (fr)
DK (1) DK1480622T3 (fr)
ES (1) ES2318147T3 (fr)
GB (1) GB0205253D0 (fr)
HK (1) HK1078006A1 (fr)
MX (1) MXPA04008543A (fr)
MY (1) MY138752A (fr)
PL (1) PL208133B1 (fr)
PT (1) PT1480622E (fr)
SA (1) SA03240089B1 (fr)
TW (1) TWI296198B (fr)
WO (1) WO2003074031A1 (fr)
ZA (1) ZA200407998B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US7749533B2 (en) * 2003-05-07 2010-07-06 Akina, Inc. Highly plastic granules for making fast melting tablets
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US7888412B2 (en) 2004-03-26 2011-02-15 Board Of Trustees Of The University Of Alabama Polymer dissolution and blend formation in ionic liquids
US7550520B2 (en) 2005-05-31 2009-06-23 The University Of Alabama Method of preparing high orientation nanoparticle-containing sheets or films using ionic liquids, and the sheets or films produced thereby
US8883193B2 (en) 2005-06-29 2014-11-11 The University Of Alabama Cellulosic biocomposites as molecular scaffolds for nano-architectures
EP1745775B1 (fr) * 2005-07-19 2008-05-28 Ethypharm Formulations de rétention gastrique et procédé de préparation
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
PT2054040E (pt) * 2006-08-16 2011-06-30 Novartis Ag Método para produzir dispersões sólidas de compostos terapêuticos altamente cristalinos
EP2051696A2 (fr) * 2006-08-18 2009-04-29 Morton Grove Pharmaceuticals, Inc. Compositions liquides stables de lévétiracétam et procédés
KR20090090387A (ko) * 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
EP2150245A1 (fr) * 2007-04-27 2010-02-10 Schering-Plough Ltd. Composés et procédés pour améliorer la solubilité du florfénicol et antibiotiques structurellement liés utilisant des cyclodextrines
WO2009105236A1 (fr) 2008-02-19 2009-08-27 The Board Of Trustees Of The University Of Alabama Systèmes de liquides ioniques pour le traitement de biomasse, leurs composants et/ou dérivés et leurs mélanges
JP5519639B2 (ja) * 2008-04-28 2014-06-11 フォーマック ファーマシューティカルズ ナムローゼ フェンノートシャップ 秩序化したメソポーラスシリカ材料
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
WO2010078300A1 (fr) 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Liquides ioniques à double fonction et sels de ceux-ci
US9096743B2 (en) 2009-06-01 2015-08-04 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
US8784691B2 (en) 2009-07-24 2014-07-22 Board Of Trustees Of The University Of Alabama Conductive composites prepared using ionic liquids
BRPI1002023A2 (pt) * 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN101843586B (zh) * 2010-04-29 2012-05-23 山东迅达康兽药有限公司 一种含有氟苯尼考的可溶于水的微粉及其制备方法
CN102178068B (zh) * 2010-07-06 2013-07-31 新疆农业大学 一种饲料添加剂的使用方法
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
AR086249A1 (es) * 2011-05-02 2013-11-27 Aptalis Pharmatech Inc Composiciones de tabletas de disolucion rapida de administracion vaginal
EP2537518A1 (fr) * 2011-06-24 2012-12-26 Elanco Animal Health Ireland Limited Formulation de granule d'azaperone à solution rapide
WO2014106962A1 (fr) 2013-01-07 2014-07-10 삼아제약 주식회사 Nouvelle formulation de granules à dissolution rapide ayant une solubilité améliorée
BR102013020508B1 (pt) * 2013-08-12 2021-01-12 Ems S/A. Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
LT3258920T (lt) 2015-02-17 2023-07-25 Universiteit Gent Kieta farmacinė dozavimo forma, tinkanti tirpinti geriamajame vandenyje ir vartoti kaip geriamąjį vaistinį tirpalą
CN109069515A (zh) * 2016-03-04 2018-12-21 安比拉神经疗法公司 用于治疗成瘾或物质使用障碍的组合物和方法
CN114657730A (zh) 2016-03-25 2022-06-24 天然纤维焊接股份有限公司 用于生产焊接基质的方法、工艺和设备
JP7114484B2 (ja) 2016-05-03 2022-08-08 ナチュラル ファイバー ウェルディング インコーポレーテッド 染色及び溶着された基材を製造するための方法、プロセス、及び装置
CN108210501B (zh) * 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
CN110582278B (zh) 2017-03-10 2023-04-18 伊姆贝拉神经疗法公司 药物组合物及其用途
US10941258B2 (en) 2017-03-24 2021-03-09 The Board Of Trustees Of The University Of Alabama Metal particle-chitin composite materials and methods of making thereof
PE20211334A1 (es) * 2018-09-06 2021-07-22 Yissum Research Development Company Of The Hebrew Univ Of Jerusalen Ltd Formula antibiotica inyectable de liberacion sostenida
CN114532451B (zh) * 2022-02-28 2023-06-02 安徽科技学院 一种促进肉羊育肥的中药组方添加剂及制备方法
CN116019771A (zh) * 2022-09-09 2023-04-28 沈阳伟嘉生物技术有限公司 一种氟苯尼考可混饮无定形固体分散体制剂及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639637A (en) * 1968-04-23 1972-02-01 Richardson Merrell Inc Water dispersible diethylstilbestrol compositions
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
AT396250B (de) * 1984-09-14 1993-07-26 American Cyanamid Co Verfahren zur herstellung von neuen antibiotisch wirkenden verbindungen
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IT1187751B (it) 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
GB8913889D0 (en) 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
ES2109377T3 (es) * 1991-12-18 1998-01-16 Warner Lambert Co Proceso para la preparacion de una dispersion solida.
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
US6153206A (en) * 1997-08-27 2000-11-28 Revlon Consumer Products Corporation Cosmetic compositions
CN1277550A (zh) 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
US20010046526A1 (en) * 2000-04-19 2001-11-29 C-Quest Treatment of fungal infections
WO2001083093A1 (fr) * 2000-05-03 2001-11-08 Silva Joe D Procede et dispositif pour produire des formulations posologiques liquides
WO2002017877A2 (fr) * 2000-08-31 2002-03-07 Universiteit Gent Compositions pour granules pharmaceutiques a liberation controlee destinees a limiter les effets secondaires de medicaments
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
EP1469829B1 (fr) * 2002-02-01 2016-01-27 Bend Research, Inc Formes posologiques a liberation immediate, contenant des dispersions medicamenteuses solides
GB0205253D0 (en) 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them

Also Published As

Publication number Publication date
KR20040091099A (ko) 2004-10-27
GB0205253D0 (en) 2002-04-17
CA2477890C (fr) 2011-05-10
TWI296198B (en) 2008-05-01
US8337897B2 (en) 2012-12-25
ATE418327T1 (de) 2009-01-15
MXPA04008543A (es) 2004-12-06
PL208133B1 (pl) 2011-03-31
TW200305446A (en) 2003-11-01
ES2318147T3 (es) 2009-05-01
AR038880A1 (es) 2005-02-02
DK1480622T3 (da) 2009-02-16
US20070009592A1 (en) 2007-01-11
EP1480622B1 (fr) 2008-12-24
PL372579A1 (en) 2005-07-25
US20050058705A1 (en) 2005-03-17
PT1480622E (pt) 2009-03-06
DE60325461D1 (de) 2009-02-05
SA03240089B1 (ar) 2008-07-12
CN1638738A (zh) 2005-07-13
US20110027377A1 (en) 2011-02-03
CA2477890A1 (fr) 2003-09-12
WO2003074031A1 (fr) 2003-09-12
BR0308231A (pt) 2004-12-28
MY138752A (en) 2009-07-31
AU2003215449A1 (en) 2003-09-16
CN1638738B (zh) 2012-06-06
ZA200407998B (en) 2006-06-28
AU2003215449B2 (en) 2007-07-26
US8349366B2 (en) 2013-01-08
US20110008454A1 (en) 2011-01-13
EP1480622A1 (fr) 2004-12-01

Similar Documents

Publication Publication Date Title
HK1078006A1 (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
IL165511A0 (en) A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same
IL200849A0 (en) Pharmaceutical composition comprising bisphosphonate for oral application and a process for its prepatrtion
GB0214013D0 (en) Pharmaceutical product
GB0229021D0 (en) Pharmaceutical pellets comprising tamsulosin and a process for making the same
IL215617A0 (en) Substituted pyrrolo-pyrazole derivatives and process for their preparation
AU2003250340A8 (en) Process for making a coupled block copolymer composition and the resulting composition
EP1603593A4 (fr) Composition pharmaceutique
EP1553925A4 (fr) Forme posologique orale a liberation modifiee
TWI319317B (en) Modified release pharmaceutical formulation
AU2003260803A8 (en) Sustained release pharmaceutical composition
AU2003250372A8 (en) Pharmaceutical composition
IL166039A0 (en) New effector conjugates process for their production and their pharmaceutical use
EP1496913A4 (fr) Compositions pharmaceutiques neuroprotectrices a base de spirostenol
PL376840A1 (pl) Kompozycja farmaceutyczna o przedłużonym uwalnianiu
IL165069A0 (en) Immediate release pharmaceutical formulation
HUP0203976A3 (en) Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
EP1478353A4 (fr) Composition pharmaceutique a liberation soutenue
AP1826A (en) A controlled release pharmaceutical composition and a process for preparing the same
HK1065477A1 (en) Pharmaceutical composition
HK1070360A1 (en) Benzo ÄaÜpyranoÄ3,2-hÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions thereof
HK1079775A1 (en) New 4-oxo-4,6,7,8-tetrahydro-pyrrolo Ä1,2-AÜpyrazine-6-carboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
AP1856A (en) process for making larvicidal evaporation suppressant powder
HUP0303141A3 (en) Pharmaceutical compositions and process for their preparation
EG24434A (en) A new product for the fight against ticks and the process for the production

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF THE NAME OF THE INVENTOR FROM VERVAET, KRIS K. TO VERVAET, CHRIS C

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160305